Cargando…

Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816975/
http://dx.doi.org/10.2147/BTT.S54093
_version_ 1782478000948772864
collection PubMed
description
format Online
Article
Text
id pubmed-3816975
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-38169752013-11-07 Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum] Biologics Corrigendum Dove Medical Press 2013 2013-10-31 /pmc/articles/PMC3816975/ http://dx.doi.org/10.2147/BTT.S54093 Text en © 2013 Keohane et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.
spellingShingle Corrigendum
Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
title Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
title_full Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
title_fullStr Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
title_full_unstemmed Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
title_short Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
title_sort treatment and management of myelofibrosis in the era of jak inhibitors [corrigendum]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816975/
http://dx.doi.org/10.2147/BTT.S54093